Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRV liquid vaccine in healthy infants in Vietnam
NCT00345956Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 2006
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in rotavirus infection comparing HRV Vaccine with Placebo (2 arms). Primary endpoints: Anti-rotavirus IgA antibody seroconversion at 2 months and Solicited and Unsolicited Adverse Events. Started Sep 2006; status: completed.
02
Drugs
human rotavirus vaccine, live attenuated
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00345956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345956.